These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 9049187

  • 21. Altered expression of the epidermal growth factor receptor and transforming growth factor-alpha during multistage skin carcinogenesis in SENCAR mice.
    Rho O, Beltrán LM, Gimenez-Conti IB, DiGiovanni J.
    Mol Carcinog; 1994 Sep; 11(1):19-28. PubMed ID: 7916986
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Transcriptional repression of catalase in mouse skin tumor progression.
    Kwei KA, Finch JS, Thompson EJ, Bowden GT.
    Neoplasia; 2004 Sep; 6(5):440-8. PubMed ID: 15548352
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells.
    Story MT, Hopp KA, Meier DA.
    Prostate; 1996 Apr; 28(4):219-26. PubMed ID: 8602397
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Relationship between the expression of differentiation-specific keratins 1 and 10 and cell proliferation in epidermal tumors.
    Kartasova T, Roop DR, Yuspa SH.
    Mol Carcinog; 1992 Apr; 6(1):18-25. PubMed ID: 1380247
    [Abstract] [Full Text] [Related]

  • 30. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K, Beltrán L, Rupp T, DiGiovanni J.
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [Abstract] [Full Text] [Related]

  • 31. Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa.
    Pasini FS, Brentani MM, Kowalski LP, Federico MH.
    Head Neck; 2001 Sep; 23(9):725-32. PubMed ID: 11505481
    [Abstract] [Full Text] [Related]

  • 32. Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition.
    Sabbineni H, Verma A, Somanath PR.
    J Cell Physiol; 2018 Nov; 233(11):8418-8428. PubMed ID: 29856065
    [Abstract] [Full Text] [Related]

  • 33. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
    Vagenas K, Spyropoulos C, Gavala V, Tsamandas AC.
    J Surg Res; 2007 May 15; 139(2):182-8. PubMed ID: 17270215
    [Abstract] [Full Text] [Related]

  • 34. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
    Yu H, Mrowietz U, Seifert O.
    Acta Derm Venereol; 2009 May 15; 89(4):351-6. PubMed ID: 19688145
    [Abstract] [Full Text] [Related]

  • 35. Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung.
    Coker RK, Laurent GJ, Jeffery PK, du Bois RM, Black CM, McAnulty RJ.
    Thorax; 2001 Jul 15; 56(7):549-56. PubMed ID: 11413354
    [Abstract] [Full Text] [Related]

  • 36. The expression of transforming growth factor beta in pregnant rat myometrium is hormone and stretch dependent.
    Shynlova O, Tsui P, Dorogin A, Langille BL, Lye SJ.
    Reproduction; 2007 Sep 15; 134(3):503-11. PubMed ID: 17709568
    [Abstract] [Full Text] [Related]

  • 37. Molecular mechanisms of malignant conversion in skin carcinogenesis.
    Yuspa SH, Greenhalgh DA.
    Princess Takamatsu Symp; 1989 Sep 15; 20():281-8. PubMed ID: 2518687
    [Abstract] [Full Text] [Related]

  • 38. A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis.
    Navarro P, Gómez M, Pizarro A, Gamallo C, Quintanilla M, Cano A.
    J Cell Biol; 1991 Oct 15; 115(2):517-33. PubMed ID: 1918152
    [Abstract] [Full Text] [Related]

  • 39. Effect of cathepsin D and prostate specific antigen on latent transforming growth factor-beta in breast cancer cell lines.
    Wong SF, Seow HF, Lai LC.
    Malays J Pathol; 2003 Dec 15; 25(2):129-34. PubMed ID: 16196369
    [Abstract] [Full Text] [Related]

  • 40. Aberrant expression during two-stage mouse skin carcinogenesis of a type I 47-kDa keratin, K13, normally associated with terminal differentiation of internal stratified epithelia.
    Nischt R, Roop DR, Mehrel T, Yuspa SH, Rentrop M, Winter H, Schweizer J.
    Mol Carcinog; 1988 Dec 15; 1(2):96-108. PubMed ID: 3076454
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.